You have 9 free searches left this month | for more free features.

City

Guangzhou (2)

Condition

Non-small Cell Lung Cancer (2)

Non Small Cell Lung Cancer (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Shenzhen TargetRx, Inc. (3)

Intervention

tgrx-326 (3)

crizotinib (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

tgrx-326

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Non Small Cell Lung Cancer Trial (TGRX-326, Crizotinib)

Not yet recruiting

Non Small Cell Lung Cancer

TGRX-326
Crizotinib

(no location specified)

Oct 8, 2023

NSCLC Trial in Guangzhou (TGRX-326)

Recruiting

Non-small Cell Lung Cancer

TGRX-326

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center

Jun 29, 2022

NSCLC Trial in Guangzhou (TGRX-326)

Recruiting

Non-small Cell Lung Cancer

TGRX-326

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center

Jul 18, 2023